In Vivo Tests for Evaluation of Pulmonary Surfactant
Before using surfactant preparations in animal experiments or in clinical trials, it is necessary that they fulfill specific physical properties [5, 9]. Some of these essential physical requirements for an effective lung surfactant have been reviewed by many workers [1, 4, 7, 27]. However, different clinical results concerning arterial oxygen tension have been reported. A marked improvement in arterial oxygen tension after surfactant replacement has been reported by Fujiwara et al. , whereas no effect on arterial oxygen tension was observed by Milner et al. , Morley et al.  and Wilkinson et al. . All these workers used a surfactant which was highly effective in in vitro studies. This poses the question as to whether the physical characteristics of surfactant, obtained through in vitro studies, can be also be considered as a method of testing a preparation which has to be physiologically active in the lung.
KeywordsAdult Respiratory Distress Syndrome Pulmonary Surfactant Arterial Oxygen Tension Viral Pneumonia Peak Airway Pressure
Unable to display preview. Download preview PDF.
- 5.Fujiwara T, Tanaka Y, Takei Y (1979) Surface properties of artificial surfactant in comparison with natural and synthetic surfactant lipids. IRCS Med Sci 7: 311Google Scholar
- 10.Lachmann B, Fujiwara T, Chida S, Morita T, Konishi M, Nakamura K, Maeta H (1981) Improved gas exchange after tracheal instillation of surfactant in the experimental adult respiratory distress syndrome (abstract) Crit Care Med 9: 158Google Scholar
- 12.Lachmann B (1982) Animal models for the in vivo testing of exogenous surfactant (abstract). Mackinac workshop on exogenous surfactant, October 6–9, 1982Google Scholar
- 14.Lachmann B, Danzmann E, Haendly B, Jonson B (1982) Ventilator settings and gas exchange in respiratory distress syndrome. In: Prakash O (ed) Applied physiology in clinical respiratory care. Nijhoff, The Hague, pp 141–176Google Scholar
- 17.Lachmann B (1986) New aspects in pathophysiology and therapy of respiratory distress syndrome: criteria for characterisation of exogenous surfactant in surfactant deficient animal models. In: Cosmi EV, Di Renzo GC (eds) Selected topics in perinatal medicine. Rome, CIC, pp 177–198Google Scholar
- 18.Lachmann B, Fujiwara T, Chida S, Morita T, Konishi M, Nakamura K, Maeta H (1983) Surfactant replacement therapy in the experimental adult respiratory distress syndrome (ARDS). In: Cosmi, Scarpelli (eds) Pulmonary surfactant system. Elsevier, Amsterdam, pp 231–235Google Scholar
- 19.Lachmann B, Berggren P, Curstedt T, Grossman G, Robertson B (1984) Surfactant replacement in experimental respiratory distress syndrome induced by lung lavage. Prog Resp Res 28:251–256 In: Robertson B, Van Golde LMG, Batenburg JJ (eds) Pulmonary surfactant.Google Scholar
- 20.Lachmann B, Danzmann E (1984) Adult respiratory distress syndrome. Elsevier, Amsterdam, pp 505–548Google Scholar
- 25.Noack K, Bergmann K CH, Eckert H, Luther P, Tischner H, Pohl WD (1982) Tierexperimentelles Modell einer aerogenen Influenza-Infektion. Z Erkrank Atm-Org 159: 155–165Google Scholar